Developers of biosimilars -- medicines that are near-identical copies of biologic drugs -- will no longer be required to conduct clinical trials to prove effectiveness.

In a novel ABO-incompatible kidney transplantation, investigators converted the deceased donor kidney’s blood type.

(HealthDay News) — Two mechanisms of structural and functional retinal impairment based on papilledema severity have been identified among patients with idiopathic intracranial hypertension (IIH), ...

For patients with cardiac arrest and a shockable rhythm, automated external defibrillators (AEDs) in private homes improve outcomes but cannot be considered cost-effective at current pricing, ...

Bacillus Calmette-Guérin (BCG) shortages and the fragile BCG supply chain have created a bladder cancer treatment vacuum.

SARS-CoV-2 mRNA vaccination within 100 days of ICI initiation was associated with increased overall survival in patients with NSCLC or metastatic melanoma.

The FDA has expanded the approval of Winrevair to include treatment of adults with PAH WHO Group 1 to improve exercise capacity and WHO FC, and reduce the risk of clinical worsening events including ...

While mycophenolate mofetil is standard of care treatment for lupus nephritis, belimumab might be an alternative.

Patient and graft survival similar for patients receiving DCD-V from MAiD donation versus conventional DCD-III grafts.

Associations seen for HIV infection, SARS-CoV-2 infection, other viral infections with coronary heart disease, stroke.

The Food and Drug Administration (FDA) has granted Priority Review to enfortumab vedotin-ejfv (Padcev ™) in combination with pembrolizumab (Keytruda ®) as a neoadjuvant treatment and then continued ...

The phase 3 ALBAN trial tested atezolizumab plus BCG in BCG-naïve patients with high-risk, non-muscle-invasive bladder cancer (NMIBC).